FibroBiologics digitally signed a securities purchase agreement with Peak One Opportunity Fund on Oct 7, 2026, to sell a $1M convertible debenture. This secondary offering of approximately 89% of the debt's face value is potentially dilutive.
FibroBiologics digitally signed a securities purchase agreement with Peak One Opportunity Fund on Oct 7, 2026, to sell a $1M convertible debenture. This secondary offering of approximately 89% of the debt's face value is potentially dilutive.